35017-00-6

Upstream product

• 19312-05-1 N-(2-hydroxyl-1,1-dimethylethyl) benzamide 
• 35016-98-9 N-(1-{(4R,5S)-5-[(R)-((R)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-hydroxy-methyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-1-methyl-ethyl)-benzamide 
• 98-88-4 benzoyl chloride 
• 7563-05-5 4,4-dimethyl-2-phenyl-5-oxazolone 
• 1192017-87-0 N-(1-(methoxy(methyl)amino)-2-methyl-1-oxopropan-2-yl)benzamide 
• 582-61-6 benzoyl azide 
• 35016-99-0 N-((2R,3R,4R,5R)-2,3,4,5,6-Pentahydroxy-1,1-dimethyl-hexyl)-benzamide 
• 38584-22-4 5-methoxy-4,4-dimethyl-2-phenyl-4,5-dihydro-oxazole 

Downstream Products

• 57224-51-8 N-benzoyl-2-methylalanine 
• 107258-98-0 cis-ethyl 4-benzoylamino-4-methyl-2-pentenoate 
• 107258-97-9 trans-ethyl 4-benzoylamino-4-methyl-2-pentenoate 
• 175026-31-0 N-(4-ethoxy-2-hydroxy-1,1-dimethylbut-3-ynyl)benzamide 
• 1260435-46-8 C₁₁H₁₂FNO 
• 1260435-57-1 5,5-dimethyl-3-phenyl-5,6-dihydro-4H-1,2,4-oxadiazin-6-ol 
• 107258-99-1 ethyl 4-benzoylamino-4-methyl-3-nitromethylpentanoate 
• 107259-00-7 4-(1-benzoylamino-1-methylethyl)-2-pyrrolidone 
• 107259-01-8 3-(1-benzylamino-1-methylethyl)pyrrolidine 
• 175026-35-4 N-(2-tert-butyldimethylsiloxy-4-ethoxy-1,1-dimethylbut-3-ynyl)benzamide 

Relevant academic research and scientific papers

DAST-mediated cyclization of α,α-disubstituted-α- acylaminoketones: Efficient and divergent synthesis of unprecedented heterocycles

The design of a new potent nonsteroidal ecdysone agonist led to the discovery of a diethylaminosulfur trifluoride (DAST)-mediated cyclization of α,α-disubstituted-α-acylaminoketones. The resulting fluorooxazolines can be ring-opened or selectively substit

Synthesis of cyclic and acyclic imides, sulfonimides, and N-carbobenzyloxyamides by ketene trapping

A convenient and general method for the synthesis of cyclic and acyclic imides, sulfonimides, and N-benzyloxycarbonyl amides via the inter- and intramolecular trapping of ketenes has been developed.Heating the corresponding amido, sulfonamido, and carbama

Synthesis and structure-activity relationships of 7-[3-(1- aminoalkyl)pyrrolidinyl]- and 7-[3-1-aminocycloalkyl)pyrrolidinyl]-quinolone antibacterials

A series of 7-[3-(1-aminoalkyl and 1-aminocycloalkyl)-1- pyrrolidinyl]quinolones have been prepared and their biological properties evaluated. Among them, 1-(S)-aminoalkyl derivatives exhibited potent antibacterial activities against gram-positive and gram-negative organisms. They had moderate lipophilicity and high aqueous solubility compared to their aminomethyl counterparts; e.g., the 3-(1-aminoethyl)-1-pyrrolidinyl compound (83) showed superior pharmacokinetic properties to its aminomethyl counterpart (6).

Pyridonecarboxylic acid derivatives

This invention provides novel pyridonecarboxylic acid derivatives having a quite high antimicrobial activity. The derivatives have the following formula: STR1 wherein R1, R2 and R3 represent each a hydrogen or C1 -C6 alkyl group; R4 represents an ethyl, 2-fluoroethyl, vinyl, isopropyl, isopropenyl or cyclopropyl group; and X represents CH, C-F, C-Cl or N wherein (i) one of R1, R2 and R3 represents a hydrogen or C1 -C6 alkyl group, and (ii) either R1 forms a methylene chain having 2 to 4 carbon atoms together with R2 or R3, or R2 and R3 form together an alkylene chain having 2 to 5 atoms and R4 represents an ethyl, 2-fluorethyl, vinyl, isopropyl, isopropenyl or cyclopropyl group and X represents CH, C-F, or C-Cl and salt thereof.